Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Ames assay: negative (BASF, 2009)


HPRT: negative (BASF 2015)


MNT in vitro: negative (BASF 2015)

Link to relevant study records

Referenceopen allclose all

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2009-10-27 to 2009-11-20
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
liver S9 mix from induced rats
Test concentrations with justification for top dose:
22 µg - 5600 µg/plate (standard plate test, all tester strains)
1 µg - 250 µg/plate (preincubation test: TA 1535, TA 1537)
2 µg - 500 µg/plate (preincubation test: TA 100, TA 98)
22 µg - 5600 µg/plate (preincubation test: E. coli)
Vehicle / solvent:
- Vehicle used: DMSO
- Justification for choice of solvent/vehicle: Due to the limited solubility of the test item in water, DMSO was used as vehicle, which had been demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available.
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
2-AA
Positive control substance:
other: 2-aminoanthracene
Remarks:
with S9 mix (TA98, TA100, TA1535, TA1537, WP2 uvr A)
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
MNNG
Positive control substance:
other: N-methyl-N`-nitro-N-nitrosoguanidine
Remarks:
without S9 mix (TA1535, TA100)
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
NOPD
Positive control substance:
other: 4-nitro-o-phenylenediamine
Remarks:
without S9 mix (TA 98)
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
AAC
Positive control substance:
9-aminoacridine
Remarks:
without S9 mix (TA1537)
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
4-NQO
Positive control substance:
4-nitroquinoline-N-oxide
Remarks:
without S9 mix (WP2 uvr A)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 20 min
- Exposure duration: 48 -72 hours in the dark

SELECTION AGENT (mutation assays): not used

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
- Method: other: reduced background lawn, decrease in number of revertants and reduction in the titer
Evaluation criteria:
Generally, the experiment is considered valid if the following criteria are met:
- The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain.
- The sterility controls revealed no indication of bacterial contamination.
- The positive control items both with and without S9 mix induced a distinct increase in the number of revertant colonies within the range of the historical positive control data or above.
- The titer of viable bacteria was ≥ 10^8/mL

The test item is considered positive in this assay if the following criteria are met:
- A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.

A test item is generally considered non-mutagenic in this test if:
-The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in at least two experiments carried out independently of each other.
Key result
Species / strain:
E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Remarks:
Raw data is listed under "any other information on results incl. tables"
Cytotoxicity / choice of top concentrations:
other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Remarks:
Raw data is listed under "any other information on results incl. tables"
Cytotoxicity / choice of top concentrations:
other: A bacteriotoxic effect was observed with the Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: Salmonella strains only depending on the strain and test conditions from about 125 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No
- Effects of osmolality: No
- Evaporation from medium: No
- Water solubility: No
- Precipitation: No test item precipitation was found with and without S9 mix.

RANGE-FINDING/SCREENING STUDIES: Not performed

COMPARISON WITH HISTORICAL CONTROL DATA:
The number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain. In addition, the positive control items both with and without S9 mix induced a significant increase in the number of revertant colonies within the range of the historical positive control data or above.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
A bacteriotoxic effect (reduced his- background growth, decrease in the number of his+ revertants, reduction in the titer) was observed in the standard plate test using the Salmonella strains depending on the strain and test conditions from about 250 μg/plate onward. In the preincubation assay bacteriotoxicity (reduced his- background growth, decrease in the number of his+ revertants, reduction in the titer) was observed depending on the strain and test conditions using the Salmonella strains from about 125 μg/plate onward. With the tester strain E. coli WP2uvrA no bacteriotoxicity was observed in all experiments up to the highest required concentration.

Table 1: First standard plate test

Dose (µg/plate) Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium and E.coli
TA1535 TA1537 TA98 TA100 WP2 uvr A
Results with S9 mix
Solvent control 18 10 37 128 48
Positive control 125 177 674 896 227

22

20

10 36 119 48

112

19

9 29 101 41
560 9 B 3 B 15 B 10 B 48
2800 0 B 0 B 0 B 0 B 39
5600 0 B 0 B 0 B 0 B 43
Results without S9 mix
Solvent control 18 11 33 120 42
Positive control 864 460 738 861 895

22

17

12 31 112 47
112 16 8 23 92 44
560 8 B 3 B 14 B 34 B 43
2800 0 B 0 B 0 B 0 B 44
5600 0 B 0 B 0 B 0 B 36

B= reduced background lawn

Table 2: Second standard plate test with S. typhimurium strains

Dose (µg/plate) Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium and E.coli
TA1535 TA1537 TA98 TA100
Results with S9 mix
Solvent control 20 9 32 94
Positive control 150 174 726 864

31.3

21

9 22 90

62.5

17

8 27 86
125 18 8 34 89
250 12 7 22 87
500 8 B 3 B 10 B 23 B
Results without S9 mix
Solvent control 21 8 33 90
Positive control 992 456 471 945

31.3

21

8 32 85

62.5

20

7 29 77
125 19 8 31 90
250 11 6 34 78
500 6 B 4 B 13 B 21 B

B= reduce background lawn

Table 3 preincubation test with TA1535, TA1537

Dose (µg/plate) Mean number of revertant colonies/3 replicates
TA1535 TA1537
Results with S9 mix
Solvent control 18 8
Positive control 140 134

1

17 5

5

16 7
25 17 7
125 15 6
250 5 B 3 B
Results without S9 mix
Solvent control 18 10
Positive control 573 380

1

19

7

5

19

10
25 16 8
125 11 6
250 7 B 1 B

B= reduced background lawn

Table 4 preincubation test with TA98, TA100

Dose (µg/plate) Mean number of revertant colonies/3 replicates
TA100 TA 98
Results with S9 mix
Solvent control 93 30
Positive control 939 566

2

98

25

10

101

29

50 87 25
250 83 27
500 19 B 9 B
Results without S9 mix
Solvent control 95 28
Positive control 1038 414

2

94

25

10

97

32
50 103 22
250 81 24
500 19 B 14 B

B = reduced background lawn

Table 5 preincubation test with WP2 uvr A

Dose (µg/plate) Mean number of revertant colonies/3 replicates
WP2 uvr A
Results with S9 mix
Solvent control

33

Positive control

240

22

31

112

34

560

29

2800

34

5600

33

Results without S9 mix
Solvent control

48

Positive control

872

22

45

112

45

560

47

2800

46

5600

51

Endpoint:
in vitro cytogenicity / micronucleus study
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
GLP compliance:
yes (incl. QA statement)
Type of assay:
in vitro mammalian cell micronucleus test
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Details on mammalian cell type (if applicable):
- Type and identity of media: MEM (minimal essential medium)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
Metabolic activation:
with and without
Metabolic activation system:
rat liver S9 induced with Phenobarbital/β-naphthoflavone
Test concentrations with justification for top dose:
Experiment IA + II: 4.2; 8.4; 16.9; 33.7; 67.4; 134.9; 269.8; 539.5; 1079.0; 2158.0 (with S9 mix/ 4h)
Experiment IB: 0.08; 0.16; 0.3; 0.6; 1.3; 2.5; 5.0; 10.0; 20.0; 4.0 (without S9 mix /4 h)
Experiment II: 0.03; 0.07; 0.13; 0.26; 0.53; 1.05; 2.1; 4.2; 8.4; 16.9 (without S9 mix/24h)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
cyclophosphamide
mitomycin C
other: Griseofulvin
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: 4 h or 24 h
- Fixation time (start of exposure up to fixation or harvest of cells): 24 h

NUMBER OF REPLICATIONS: 2

NUMBER OF CELLS EVALUATED: 2000

DETERMINATION OF CYTOTOXICITY
- Method: relative increase in cell counts (RICC) + proliferation index (PI)

Evaluation criteria:
A test item can be classified as mutagenic if:
− The number of micronucleated cells exceeds both the value of the concurrent negative control and the range of the historical negative control data.
− A significant, dose-related and reproducible increase in the number of cells containing micronuclei is observed
Key result
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid

Summary of results

Exp.

Preparation interval

Test item concentration in µg/ml

Proliferation Index

RICC in %

Cytotoxicity in %

Micronucleated Cells*                   in %

Exposure period 4 hrs without S9 mix

IB

24hrs

Solvent control1

2.74

100

0

1.20

Positive control2

2.42

19

81

7.45S

0.08

2.86

171

0#

0.90

0.16

2.83

89

11

0.65

0.3

2.86

44

56

0.90

1.3

2.62

16

84

0.85

2.5

2.66

-20

n.a.

0.60

Exposure period 24 hrs without S9 mix

II

24 hrs

Solvent control1

2.88

100

0

0.85

 

 

Positive control3

2.55

63

37

7.95S

0.26

2.93

80

20

1.20

0.53

2.93

54

46

1.20

1.05

2.92

66

34

1.45

2.1

2.80

21

79

0.95

* The number of micronucleated cells was determined in a sample of 2000 cells

#Not cytotoxic since the RICC is higher than the solvent control value

SNumber of micronucleated cells statistically significantly higher than corresponding control values

n.a. Not analysable, because the cell number of the solvent control or treated cultures was lower after treatment

1DMSO 0.5 % (v/v)

2Mitomycin C 0.1μg/mL

3Griseofulvin 8.0μg/mL

Exposure period 4 hrs with S9 mix

IA

24 hrs

Solvent control1

2.31

100

0

0.60

 

 

Positive control2

1.64

0

100

17.20S

16.9

2.40

64

36

1.15

33.7

2.26

32

38

0.60

67.4

2.34

54

46

0.65

134.9

2.20

29

71

0.65

269.8

2.13

-52

n.a.

 

II

24 hrs

Solvent control1

2.84

100

0

1.20

 

 

Positive control2

1.64

-15

n.a.

12.45S

33.7

2.78

61

39

0.90

67.4**

2.74

84

16

1.45

134.9**

2.63

75

25

1.58

269.8**

2.38

34

66

1.43

* The number of micronucleated cells was determined in a sample of 2000 cells

** The number of micronucleated cells was determined in a sample of 4000 cells

SNumber of micronucleated cells statistically significantly higher than corresponding control values

n.a. Not analysable, because the cell number of the solvent control or treated cultures was lower after treatment

1DMSO 0.5 % (v/v)

2CPA 10.0μg/mL

3CPA 15.0 μg/mL

Endpoint:
in vitro gene mutation study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
GLP compliance:
yes (incl. QA statement)
Type of assay:
mammalian cell gene mutation assay
Target gene:
hypoxanthine-guanine phosphoribosyl transferase (HPRT)
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Details on mammalian cell type (if applicable):
- Type and identity of media: MEM (minimal essential medium)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
Metabolic activation:
with and without
Metabolic activation system:
rat liver mix S9 (induced with Phenobarbital/β-naphthoflavone)
Test concentrations with justification for top dose:
Test 1: 0.27; 0.55; 1.1; 2.2; 4.4 µg/mL (without S9 mix); 35.0; 70.0; 140.0; 210.0; 280.0 µg/mL (with S9 mix)
Test 2: 2.0; 3.0; 4.0; 6.0; 8.0 µg/mL (without S9 mix); 105.0; 140.0; 210.0; 245.0; 280.0 µg/mL (with S9 mix)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
7,12-dimethylbenzanthracene
ethylmethanesulphonate
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Preincubation period: 24 h
- Exposure duration: 4 h
- Expression time (cells in growth medium): 7 days
- Selection time (if incubation with a selection agent): 8 days
- Fixation time (start of exposure up to fixation or harvest of cells): 15 days

SELECTION AGENT (mutation assays): 6-thioguanine'; 11 µg/mL

NUMBER OF REPLICATIONS: 2

Evaluation criteria:
A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
Key result
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
No substantial and reproducible dose dependent increase of the mutation frequency was observed up to the maximum concentration with and without metabolic activation.
Appropriate reference mutagens (EMS and DMBA), used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.

In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, Laromer TBCH is considered to be non-mutagenic in this HPRT assay.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Ames


In a reverse gene mutation assay in bacteria according to OECD 471 and EU method B. 13 (BASF, 2009), strains of S. typhimurium (TA98, TA100, TA1535, TA1537) and E. coli (WP2 uvr A) were exposed to the test substance in DMSO at concentration ranges listed down below. A standard plate test (SPT) and a preincubation test (PIT) both with and without metabolic activation were performed.


 


22 - 5600 μg/plate (SPT, all test strains)


1 - 250 μg/plate (PIT: TA 1535, TA 1537)


2 - 500 μg/plate (PIT: TA 100, TA 98)


22 - 5600 μg/plate (PIT: E. coli)


 


Three independent experiments were performed, two standard plate tests and one preincubation test. No precipitation of the test item was found with and without S9 mix. A bacteriotoxic effect was observed only with the Salmonella strains in both the standard plate and the preincubation test from about 125 µL/plate onwards. A relevant increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S9 mix or after the addition of a metabolizing system. Thus, under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.


 


HPRT


In a study according to OECD 476, two independent experiments each with and without metabolic activation were performed to assess the potential of Laromer TBCH to induce gene mutations in mammalian cells (BASF 2015). Exposure time was 4h in all experiments. The test substance was applied up to 280 µg/mL in the presence of S9 and up to 8µg/ml without the addition of S9. Concentrations were limited by cytotoxic effects. No substantial and reproducible dose dependent increase of the mutation frequency was observed up to the maximum concentration with and without metabolic activation. Appropriate reference mutagens (EMS and DMBA), used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system. In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells.


 


MNT in vitro


In a study according to OECD 487, Chinese hamster V79 cells were exposed to Laromer TBCH and evaluated for the induction of micronuclei (BASF 2015). The maximum concentrations used were limited by the cytotoxicity of the test item. In the absence of a metabolic activation system, up to 2.5 µg/mL or 2.1 µg/mL could be used, if the cells were treated for 4h or 24h, respectively. In the presence of S9 mix, the cells were treated for 4h with up to 269.8 µg/mL. In each experimental group two parallel cultures were analysed. Per culture at least 1000 cells were evaluated for cytogenetic damage. Neither a statistically significant nor a biologically relevant increase in the number of micronucleated cells was observed after treatment with the test item. Appropriate mutagens (MMC, Griseofulvin and CPA) were used as positive controls. They induced statistically significant increases in the number of cells with micronuclei.

Justification for classification or non-classification

Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The registered substance did not cause gene mutations in bacteria or mammalian cells, nor chromosomal damage. Consequently, there is no need for classification for mutagenicity under Regulation (EC) No 1272/2008, as amended for the eighteenth time in Regulation (EU) 2022/692.